Emergent Biosolutions Inc. · NYSE:EBS
Glessner Coleen received 100,111 Emergent Biosolutions Inc. shares as an award (Form 4)
Traded Apr 29, 2026 · Filed May 1, 2026
On Apr 29, 2026, Glessner Coleen (EVP, Quality & Ethics, and CPL) received 100,111 Emergent Biosolutions Inc. shares as an award, leaving 204,219 shares. Filed May 1, 2026 (Form 4).
- Awarded
- 100,111 shares
- Holding after
- 204,219 shares
- Trading plan
- No
- Role
- EVP, Quality & Ethics, and CPL
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Apr 29, 2026 | Common Stock | Award | 100,111 | 204,219 | Direct |
Source
Related
- Emergent Biosolutions Inc.
- Glessner Coleen
- Emergent Biosolutions Inc. shareholders
- Form 4 · Glessner Coleen · Jun 10, 2026
- Form 4 · DeGolyer Donald W · Oct 7, 2026
- Form 4 · Williams Paul Anthony · Oct 5, 2026
- Schedule 13G · American Century Investment Management, Inc. · Aug 14, 2026
- Schedule 13G/A · Vanguard Capital Management LLC · Jul 31, 2026
- Schedule 13G/A · BlackRock, Inc. · Jul 28, 2026